Icahn Falls Slightly In Q1

May 15 2014 | 2:46pm ET

Carl Icahn is going to need an impressive run the rest of the year if he’s to keep up his recent torrid pace.

Icahn Enterprises lost 0.4% in the first quarter, Forbes reports. Much of the decline can be attributed to Icahn’s big bet on nutritional supplements company Herbalife, whose stock has plummeted this year amidst a number of state and federal investigations.

Icahn is still up significantly on the Herbalife investment.

The loss was offset by a big win for Icahn’s second-biggest investment at the start of the year, Forest Laboratories, which in February was acquired for $25 billion.

Icahn has returned an annualized 27% over the past five years, including a 30.8% rise last year.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR